A major international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for ...

A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...

By targeting a newly uncovered weakness in prostate cancer cells, this could offer an improved treatment for the disease.

An international study reports that the combination of two drugs could significantly retard the development of a dangerous ...

The “striking” findings showed an overall upward trend in life expectancy when patients took niraparib - a targeted therapy ...

An international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for one ...

A UCLA study shows that a new treatment combining radioactive drug with radiation therapy could help delay hormone therapy ...

A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with ...

A new drug combination has offered a ray of hope for men with advanced prostate cancer.According to a research published in ...

A new study suggests cholesterol-lowering statins, when combined with apalutamide and hormone therapy, can significantly extend survival for men with ...

A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with ...

Thousands of men with incurable prostate cancer could live longer thanks to a breakthrough study that found combining two ...